1 / 20

Cost Effectiveness and Cost Benefit Analysis of Substance Abuse Treatment: Literature Review and Annotated Bibliography

Cost Effectiveness and Cost Benefit Analysis of Substance Abuse Treatment: Literature Review and Annotated Bibliography. Presented by Henrick Harwood, The Lewin Group Prepared For the Center for Substance Abuse Treatment Document available at:

taite
Download Presentation

Cost Effectiveness and Cost Benefit Analysis of Substance Abuse Treatment: Literature Review and Annotated Bibliography

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Cost Effectiveness and Cost Benefit Analysis of Substance Abuse Treatment:Literature Review and Annotated Bibliography Presented by Henrick Harwood, The Lewin Group Prepared For the Center for Substance Abuse Treatment Document available at: http://neds.calib.com/products/pdfs/litrvw/cost_lit_review/index.cfm

  2. Major Conclusions • Treatment is effective! • Treatment pays for itself! • Some treatment approaches are more cost effective . . .

  3. Major Progress in Substance Abuse Treatment • Quality of research better • Continuum of care • Patient placement criteria operationalized • Need for & composition of comprehensive services better understood • Some Guidelines and Manuals published • ASAM • also AACAP; NIH; CSAT; CSAT grantees

  4. Purpose The goals of the literature review and bibliography were to: • Develop a comprehensive list of the literature available • Identify trends in the literature in terms of topics studied and areas in need of work • Broadly characterize and summarize findings and conclusions of cost effectiveness and cost benefit studies.

  5. Citations by Type of Study • The largest number of studies have been cost benefit studies (49). • There have been fewer studies with a primary focus on cost effectiveness (29) or cost of treatment (20).

  6. Perspectives of Economic Analysis • Is some/any treatment better than no treatment? • Are some types of treatment more economical than others? • What makes treatment more cost effective? • Treatment and Distinct Client Populations • Females • Adolescents • Co-Occurring Mental Illness and Substance Abuse • Prisoners/Offenders • Opiate Substitution Therapy

  7. Conclusions • Cost benefit studies: • Recent cost benefit studies consistently find that benefits (i.e., improvements in crime, health, and social functioning) are greater than the costs of substance abuse treatment. • Cost benefit studies examining benefits in terms of reduced health care utilization and costs (“cost offsets”) find that health costs and utilization sharply increase prior to treatment initiation, then fall dramatically following the treatment period. • Cost effectiveness studies: • A handful of cost effectiveness studies conclude that less expensive treatment modalities or levels of care are more cost effective or cost beneficial than more expensive approaches.

  8. Comprehensive Cost-Offset StudiesFind Major Returns per Dollar Spent on Treatment • French et al. (2000) • $10 and $23, in two Washington State clinics. • Gerstein, Harwood, and Suter (1994) • $7 in the California public system • Finigan (1995) • $7 in the Oregon public system • Koenig, Harwood, Sullivan, and Sen (2000b) • $4 in federally-funded programs

  9. Health Costs of Substance Abusing Populations are Higher than non-Abusers • Studies of insured populations compare those treated for alcohol and drug abuse with non-abusing populations. • Those getting treatment have total health costs several times higher than the non-abusing population before treatment initiation. • Holder and Hallan (1986) • Tracked abusing and non-abusing populations for up to 4 years and found that health costs were nearly identical at the end of that period. • Goodman et al. (2000) • Found a reduction of the gap in costs between comparable treated and non-abusing populations over time. • Found cost offsets for treatment of “alcohol abuse” but probably not for “dependence” or those with mental comorbidities

  10. Health Expenditures Decline Following Substance Abuse Treatment • Analyze changes in health care utilization and costs before and after treatment = “cost offsets” • Holder and Blose (1992) • health care costs “declined by 23% to 55% from their highest pretreatment levels” • Holder & Schachtman (1987): • offsets made up for the cost of the treatment within 2 years

  11. Cost-Offsets for Treated versus Untreated Substance Abusers • Reiff, Griffiths, Forsythe, and Sherman (1981) HMO • treated population had about $500 per year lower post-referral insured health costs treatment refusers • Holder and Blose (1992) privately insured • after treatment treated alcoholics had 24 percent lower health costs than similar untreated alcoholics. Tracked 3 years. • Gerson et al., (2001) Ohio Medicaid • treated substance abusers had annual insured health costs of about $500 less than diagnosed but untreated individuals.

  12. Some Types of Treatment Are More Cost-Effective than Others (for Some Clients) • Hospital inpatient treatment versus intensive outpatient (IOP) • Alterman et al., 1994; Bachman et al., 1992; Longabaugh et al., 1983; Schneider, Mittelmeier, & Gadish, 1996) • No significant difference in outcomes. Various client populations: male and coed adults; cocaine addicts, poly substance abusers; and alcoholics. • Day treatment costs about half (or less) as much as inpatient care of same duration • Day treatment and intensive outpatient compared to less intensive regimens • Weisner et al., 2000: “step-down day treatment to IOP” versus “IOP alone” for a poly substance population; no differences in outcomes; costs almost twice as much (about $1650 versus $900) • Avants et al. (1999): for a medically indigent methadone population day treatment was no more effective than “enhanced standard” care; the more intensive treatment cost about twice the less intensive care

  13. Longer Treatment Yields Better Outcomes • Harwood, Hubbard, Collins, and Rachal (1988) • An additional day of treatment retention reduced crime-related costs during and in the year following treatment by 2 to 4 times the cost of the day of care. • French, Zarkin, Hubbard, and Rachal (1991), and French and Zarkin (1992) • Increased stay in treatment associated with significant increases in earnings & decreases in illegal earnings, But much less than the cost of the care. • Koenig et al. (2000b) • Post-treatment benefits only partially offset costs of an additional day of treatment. • Barnett & Swindle (1997) • VA inpatient 28 day programs had modestly higher outcomes than 21 day programs (78 percent success versus 75 percent) • Improvement judged too small to warrant operating 28 day programs since the costs are materially higher.

  14. Strong Benefits from Treating Women • Harwood, Fountain, Carothers, Gerstein, and Johnson (1998) • Benefits about four times greater than the cost of treatment • Svikis et al. (1997) • Successfully treated versus untreated pregnant women • Treatment cost $6,600 (day treatment) • Average NICU costs/ birth $900 for treated women vs $12,200 for untreated • Daley et al. (2000, 2001) • Pregnant women; economic returns from birth outcomes and criminal activity • Residential and combined residential-outpatient treatment most cost effective, better than standard outpatient, methadone and detoxification • Berkowitz, Brindis, Clayson, and Peterson (1996) • Mandating pregnant and parenting offenders into treatment saved about $3,000 vs. the nearly $17,000 in expense to incarcerate (and treat them in prison) for six months

  15. Adolescents Benefit From Intensive Services • Schoenwald, Ward, Hennggeler, Pickrel, and Patel (1996) • Compared “multisystemic therapy” (MST, an intensive mix of substance abuse, mental health and social services) with “usual services” for adolescents • MST reduced arrests by 26 % and time incarcerated by 46 % • Costs for therapeutic services increased 50 % over usual services • The reduction in incarceration from MST offset the increase in costs

  16. Marital Therapy is Cost Effective, Some Approaches More So than Others • Fals-Stewart, O’Farrell, and Birchler (1997) • combining behavioral couples therapy with individual counseling more effective than individual based treatment alone • no more costly • O’Farrell, Choquette, Cutter, Floyd et al. (1996) • behavioral marital therapy superior to interactional couples therapy • BMT was also less expensive

  17. Treatment for Offenders Pays for Itself • Hughey and Klemke (1996): • Offenders completing in-jail program (85%) had lower rates of re-arrest compared to similar untreated inmates. • Savings after treatment costs were $3,500/offender. • Further (but unestimated) benefits from reduced victim, police and court costs. • Maddox (1996) • Based on lit review of drug courts judged cost-effective • $5,000 in incarceration costs compared to treatments costs of $900 to $1,600 per defendant. • Recidivism rates and drug use post-treatment are also reduced.

  18. Co-Occurring Substance Abuse and Mental Illness • Jerrell and Hu (1996): • supportive, low intensity mental health plus substance abuse treatment: 12 step and case management models • cost savings of over 40% during the post-treatment period • French, Sacks, DeLeon, McKendrick, & Staines, (1999) • Mentally ill homeless substance abusers in modified TC group experienced significantly lower levels of alcohol intoxication, criminality, and depression than those in the treatment-as-usual group, and • Incurred a lower cost of health treatment, offset costs for TC services

  19. Opiate Substitution Therapy • Kraft, Rothbard, Hadley, McLellan, and Asch (1997) • Low, medium and high levels of counseling and support services • Medium level was most cost effective, but high had modestly better results • Barnett (1999) • One additional life year is saved for each $5,900 spent on methadone treatment Compares very favorably with results for other health interventions • Zaric et al. (2000) • Using methadone to reduce HIV transmission yields an additional 1 year of quality adjusted life at a cost of $8,200 • Most of the benefits are with the non-injection drug using population. • Barnett, Zaric, and Brandeau (2001) • Buprenorphine for opiate addiction is cost effective at a price of up to $30 per dose if applied to clients that would not use methadone • However, methadone is the treatment of choice for clients that will accept it

More Related